Microgenics Corporation appears in FDA records as the applicant for K110616, a premarket notification covering MAS Omni-IMMUNE and MAS Omni-IMMUNE PRO quality control materials for multiple immunoassay analytes, and as the recalling firm for a 2026 field action on the Level 1 liquid assayed integrated immunoassay control. The records place the firm within Thermo Fisher Scientific's clinical diagnostics activity while keeping the legal applicant distinct from the broader brand. Product identities, catalog references and lot numbers come from the FDA enforcement record and the manufacturer's field safety notice. [1][6][8][9]
The applicant and its documented controls
The 510(k) substantial equivalence determination for K110616 lists Microgenics Corporation as applicant and names MAS Omni-IMMUNE and MAS Omni-IMMUNE PRO as proprietary and established names. The measurand is described as quality control materials for multiple immunoassay analytes, with product code JJY and regulation section 862.1660 in the clinical chemistry panel. The accompanying 510(k) summary, prepared June 20, 2011, carries the same company name with a Thermo Fisher Scientific clinical diagnostics division address in Fremont, California. [6][8]
The FDA premarket notification database entry for K110616 classifies the device as multi-analyte controls, all kinds (assayed), and records the device name as Thermo Scientific MAS Omni-IMMUNE, MAS Omni IMMUNE. The summary states that Omni-IMMUNE is to be included with patient serum specimens when assaying for any of the listed constituents. A Thermo Scientific quality control catalog describes MAS Omni consolidated controls and notes that certain constituent levels are at levels found in source material, with no claim made for expected values of those constituents. [4][7][8]
The 2026 field action
FDA enforcement record Z-0159-2027 identifies Microgenics Corporation as the recalling firm for MAS Omni IMMUNE PRO Liquid Assayed Integrated Immunoassay Control, Level 1, catalog OPRO-101, and the sample pack, catalog OPRO-SP. The stated reason is vial-to-vial variability in lot OPRO29061A resulting in low parathyroid hormone recovery, which may delay reporting of patient PTH results. The record classifies the action as Class II, voluntary and firm initiated, with 1,366 units and worldwide distribution including US states and unspecified countries. [1]
The manufacturer's field safety notice, dated August 18, 2026 and issued as FSCA 01-26-M, states that Microgenics Corporation, part of Thermo Fisher Scientific Inc., is conducting a field safety corrective action. Its table lists OPRO-101 and OPRO-SP with lot numbers OPRO29061A and OPRO2906SA, expiration 2029-06-30, and UDI-DIs 00884883005327 and 00884883005358. The FDA recall database page for the same action carries a last-updated date of November 13, 2026. [2][9]
Brand, registration and catalog context
An FDA establishment registration and device listing page associates the product code with a proprietary name list that includes Alinity i STAT Myoglobin Controls, Alinity iSTAT CK-MB Control Kit, CRP (C-Reactive Protein), MAS Alcohol Ammonia Control, MAS Alcohol/Ammonia Max multi-pack and sample-pack entries, and further MAS items. That listing shows the breadth of control products recorded under the same registration context; it does not establish ownership of the Alinity or Dimension Vista names, which appear elsewhere as trademarks of other diagnostics companies. [4][5]
The Thermo Scientific catalog places MAS quality controls alongside LabLink 360 quality assurance software and AcroMetrix molecular quality controls and standards, and identifies Dimension Vista as a registered trademark of Siemens Healthcare Diagnostics Inc. These are publisher statements about a product family, not statements about Microgenics' total portfolio or commercial performance. [4]
What the records do and do not establish
The numbered records document a cleared control device, its intended inclusion with patient specimens during assay of listed constituents, and a corrective action on one Level 1 lot. They do not establish headquarters beyond the addresses printed in filings, ownership percentages, customer lists, certifications, or performance outside the described control use. The relationship to Thermo Fisher Scientific is stated by the manufacturer's notice and appears in the 2011 summary's division address; the legal applicant named in FDA filings remains Microgenics Corporation. [1][6][8][9]


